middle.news

LTR Pharma Completes SPONTAN Phase II Recruitment Ahead of Key Data Readout

9:16am on Tuesday 28th of April, 2026 AEST Healthcare
Read Story

LTR Pharma Completes SPONTAN Phase II Recruitment Ahead of Key Data Readout

9:16am on Tuesday 28th of April, 2026 AEST
Key Points
  • SPONTAN Phase II recruitment completed with 27 participants
  • Interim pharmacokinetic data expected in Q2 2026
  • Phase I data accepted for international presentation
  • ROXUS US commercial partner discussions progressing
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Ltr Pharma (ASX:LTP)
OPEN ARTICLE